首都医科大学附属北京世纪坛医院
English
晴 17℃~5℃ 风向:南风微风级
路径导航: 首页

肿瘤内科代表性学术论文

发表日期:2017-08-17 来源:肿瘤内科 本页责编:王占荣,左彦
人阅读

1. 胸腔内免疫治疗、化疗对恶性胸水免疫指标的影响。肿瘤防治研究. 2012,39(2):198-200.

2. CYP3A5和GSTP1基因多态性与多西他赛联合塞替派治疗转移性乳腺癌近期疗效的相关性研究.中国药学杂志.2012,47(2):127-131.

3. 115例病例分析造血干细胞对化疗药物肝毒性的保护作用。中国药物应用与监测. 2012;9(1):5-7.

4. 转移性乳腺癌上皮特异性细胞粘附分子(EpCAM)mRNA阳性循环肿瘤细胞检测及其临床价值。北京大学学报(医学版). 2012,44(2):275-280.

5. 肿瘤免疫治疗的现状与展望. 首都医科大学学报.2012;33(5):597-601.

6. 中等剂量卡培他滨单药治疗转移性乳腺癌的疗效及安全性.肿瘤防治研究.2012,39(9):1132-113.

7. Erβ相互作用蛋白HPIP的分离及其在Erβ信号途径中的作用. 重庆医学,2012,41(1):16-18.

8. 低分子肝素治疗恶性肿瘤并发深静脉血栓剂量及疗效的初步研究( 附27 例分析).实用肿瘤杂志.2012;27(3)267-270.

9. 骨髓异常增生综合征患者骨髓来源的间充质干细胞免疫功能异常. 中华微生物学和免疫学杂志,2012,32(5):449-454.

10. 骨髓和脂肪来源的间充质干细胞免疫调节作用的比较研究. 现代免疫学,2012,32(1):56-63.

11. 慢性粒细胞白血病患者骨髓来源FLK1+CD31-CD34-间充质干细胞中BCR/ABL融合基因的检测. 中国组织工程研究与临床康复,2012,16(27):5006-5010.

12. 人脂肪组织与骨髓来源间充质干细胞生物学特性的比较。中华器官移植杂志,2012,33(11):694-8.

13. 小鼠骨髓来源Flk-1+间充质干细胞分离制备与生物学特点。中国组织工程研究.2012, 16(41):7621-7624.

14. 厄洛替尼治疗吉非替尼耐药的晚期非小细胞肺腺癌的临床观察。首都医科大学学报.2012,33(5):581-585.

15. 贝伐单抗联合FOLFIRI方案一线治疗转移性结直肠癌的临床评价. 肿瘤防治研究,2012,39(8):1001-10044.

16. 高复发风险乳腺癌患者术后紫杉醇联合塞替哌大剂量辅助化疗的临床研究。肿瘤. 2013;33(4):334-338.

17. 乳腺癌恶性胸腔积液的临床特征及预后因素分析. 肿瘤防治研究. 2013;40(4):381-387.

18. 当前急需培养研究型临床肿瘤医学科学家.医学争鸣.2013;4(4):14-16.

19. 树突状细胞-细胞因子诱导杀伤细胞免疫治疗预计生存期低于3月的晚期恶性肿瘤患者.肿瘤防治研究. 2014;41(5):397-400.

20. 中国肿瘤细胞免疫治疗的现状与趋势. 转化医学研究(电子版). 2014;4(3):63-69.

21. 靶向免疫检查点的肿瘤免疫治疗现状与趋势.中国肿瘤临床.2014,41(7):415-417.

22. 肿瘤微环境及免疫调节系列研究指导乳腺癌精确治疗的临床实践.肿瘤防治研究.2014;41(11):23-26.

23. 免疫治疗背景下提高临床肿瘤教学水平的探讨.现代生物医学进展.2014;14(35):6970-6973.

24. 24.E-钙黏蛋白和N-钙黏蛋白启动子的构建及活性测定. 军事医学 2014;38(11): 860 -862.

25. 肿瘤干细胞及肿瘤发生与转移新进展.军事医学2014;38(12):994-996.

26. 吡柔比星为主联合化疗治疗复发难治性急性髓系白血病的多中心随机对照临床研究.中华血液学杂志. 2014;35(5):388-392.

27. 两种方法分离建议细胞用于高通量测序TCR组库分析的比较. 中华保健医学 杂志.2015;17(3):215-218.

28. 靶向敲低核蛋白1抑制HepG2肝癌细胞增殖及迁移.细胞与分子免疫学杂志.2015:31(6):782-788.

29. 肿瘤分子免疫学理论与临床实践课程设置的探讨.中国病案.2016;17(15):70-72.

30. VPE方案治疗成人弥散性朗格汉斯细胞组织细胞增生症3例及文献复习.中华老年多器官疾病杂志.2015;14(11):838-840.

31. 中晚期胃癌患者外周血T细胞亚群检测的临床意义.中国肿瘤临床.2017;44(5):224-228.

32. 四个半LIM结构域蛋白1对人肝癌细胞紫杉醇耐药影响的研究.中国临床药理学杂志。2017;33(12):1135-1138.

33. PD-1/PD-L1阻断剂免疫治疗不良反应及其处理原则. 中国药物应用与监测. 2017;14(3):174-178.

34. HER2-Specific T lymphocytes Kill Both Trastuzumab-resistant and Trastuzumab-sensitive Breast Cell Lines in vitro. Chin J Cancer Res.2012,24(2):143-150.

35. Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine. J Cancer Res Clin Oncol. 2012, 138:1197–1203.

36. Nongenetic risk factors and predicting efficacy for docetaxel-DILI among metastatic breast cancer patients. J Gastroen Hepatol. 2012, 27:1348–1352.

37. Global core competencies for clinical trials. Lancet. 2012,380:728.

38. Recombinant human endostatin can suppress proangiogenesis induced by side population (SP) cells from non-small lung cancer cell lines. Clin Trans Oncol. 2012;14(8):575-585 .

39. Murine bone marrow stromal cells pulsed with homologous tumor derived exosomes inhibit proliferation of liver cancer cells. Clin Trans Oncol. 2012;14(10):764-773.

40. Clinical safety of induced CTL transfusion through recombinant adeno-associated virus transfected dendritic cells vaccination in Chinese cancer patients. Clin Trans Oncol. 2012;14(9):675-681.

41. Conjunction of tumor cells with lymphocytes: Implications for tumor invasion and metastasis. Cancer Epidemiol. 2012;36(4):354-63.

42. Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients. Chin J Cancer Res 2012;24(4):323-331.

43. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia. Leukemia & Lymphoma. 2012; 53(9): 1769-78.

44. Matrix Metalloproteinase-9 Silencing by RNA Interference Promotes the Adhesive-Invasive Switch in HT1080 Human Fibrosarcoma Cells. Clin Lab. 2012, 58(3-4):313-322.

45. The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived Mesenchymal stem cells. Cell Tissue Res. 2012, 350(2):277-287.

46. Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies. Ann Oncol. 2012, 23(9):2415-2422.

47. CD44+/CD24- Breast Cancer Cells Isolated from MCF-7 Cultures Exhibit Enhanced Angiogenic Properties. Clin Trans Oncol. 2013; 15(1):46-54.

48. Specific Genetic polymorphisms of IL10-592 AA and IL10-819 TT genotype lead key role for inducing docetaxel-induced liver injury in breast cancer patients. Clin Trans Oncol. 2013 ;15(4):331-334.

49. Effects of transplanted bone marrow derived mesenchymal stem cells in animal models of acute hepatitis. Cell Tissue Res. 2013;351(3):477-86.

50. The comparison of effects of human adipose and bone marrow mesenchymal stem cells on T lymphocyte. Cell Biol Int. 2013;37(1):11-18.

51. Impact of cell dissociation on identification of breast cancer stem cells. Cancer Biomarkers. 2012/2013; (12): 125–133.

52. Impaired immuno-modulatory function of Chronic Myeloid Leukemia cancer stem cells and the possible mechnism involved in it. Cancer Immunol Immun.2013;62(4):689-703.

53. Elevated Level of Peripheral CD8+CD28- T Lymphocytes Are an Independent Predictor of Progression-Free Survival in Patients with Metastatic Breast Cancer during the course of chemotherapy. Cancer Immunol Immun. 2013; 62:1123-1130.

54. Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression free and overall survival in patients with metastatic breast cancer: reagument of such contentious therapeutic preferences. Clin Trans Oncol.2013;15(10):780-788.

55. The relationship between methylenetetrahydrofolate reductase polymorphism and hematological malignancy. Clin. Lab. 2014; 60:767-774.

56. Mouse Flk-1+Sca-1- Mesenchymal Stem Cells: Functional Plasticity In Vitro and Immunoregulation In Vivo. Transplantation.2014 Mar 15; 97(5):509-17.

57. The global contribution of outdoor air pollution to the incidence, prevalence, mortality and hospital admission for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Environ Res Public Health. 2014 Nov 14;11(11):11822-32.

58. An artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma. J Gastroen Hepatol. 2014;29(12):2014-20.

59. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience. Eur J Surg Oncol. 2014 ;40(11):1533-9.

60. Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma. PLoS One. 2014 26;9(8): e105624

61. Fruit consumption reduces the risk of esophageal cancer in Yanting, People’s Republic of China. Asia Pac J Public Health. 2015, 27(4):469-475.

62. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method. Cancer Biomark. 2015;15: 169–176.

63. Regional vriation in identified cancer care needs of early career oncologist in China, India and Pakistan. The Oncologist. 2015; 20(5):532-8.

64. Continuous DC-CIK infusions sufficiently restore CD8+cellular immunity, physical activity and improve clinical efficacy in advanced cancers patients failed and untolerated to conventional anti-cancer treatments. APJCP.2015.16(6):2419

65. Breast Cancer Challenge and Screening in China: A lesson from the sporadic data and new directions advocates. The Oncologist .2015;Jul;20(7):773-779.

66. Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining. Oncotarget .2015 Aug 21;6(24):20278-87.

67. Impaired formation of homotypic cell-in-cell structures in human tumor cells lacking alpha-catenin expression. Sci Rep. 2015 Jul 20;5:12223.

68. Laparoscopic cyst excision and Roux-Y hepaticojejunostomy for children with choledochal cysts in China: a multicenter study. Surg Endosc. 2015 ;29(1):140-4

69. Conditional Probability of Survival in Patients with Biliary Atresia after Kasai Portoenterostomy. J Pediatr Surg. 2015;50(8):1310-5.

70. A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectalcancer liver metastases. Int J Colorectal Dis. 2015;30(8):1091-102.

71. The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa. Sci Rep. 2015;5:16775.

72. A Phase I dose-escalation study of the domestic Trastuzumab in Chinese metastasis breast cancer patients. Spriger Plus. 2015 Dec 22;4:803.

73. Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy. Int J Clin Pharmacol Ther. 2015 Nov;53(11):914-922.

74. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion. Oncotarget.2015;6(380):41350-41359.

75. Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for negative metastatic breast cancers patients (aged<45). Clin Trans Oncol. 2016 Jan;18(1):82-87.

76. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: a Chinese population-based study. J Gastroen Hepatol. 2016 Mar; 31(3): 621-627.

77. Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy. Oncotarget. 2016 May 24;7(21):30408-19.

78. Enhancing the treatment effect on melanoma by heat shock protein 70-peptide complexes purified from human melanoma cell lines. Oncol Rep. 2016, 36: 1243-1250.

79. Quantitative proteome analysis of colorectal-cancer-related differential proteins. J Cancer Res Clin Oncol. 2017; 143:233–241.

80. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2. European Review for Medical and Pharmacological Sciences. 2017;21:87-94.

81. Structure-Based Design of Peptides against Her2 with Cytotoxicity on colon cancer. Artificial Cells, Nanomedicine, and Biotechnology. Artif Cells Nanomed Biotechnol. 2017;45(3):649-654.

82. Adaptive T cell responses induced by oncolytic Herpes Simplex Virus - Granulocyte- Macrophage Colony-Stimulating Factor therapy expanded by Dendritic Cell and Cytokine-Induced Killer Cell Adoptive Therapy. Oncoimmunology. 2017;6(4):e1264563(10pages).

83. Dendritic cell/cytokine induced killer cell immunotherapy combined with S-1 in patients with advanced pancreatic cancer: A prospective study. Clin Cancer Res. 2017 DOI:10.1158/1078-0432.CCR-17-0492.

阅读全文